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Sirs,
We have read with interest the article “Association of
dopamine transporter and monoamine oxidase molecular
polymorphisms with sudden infant death syndrome and
stillbirth: new insights into the serotonin hypothesis” by
Filonzi et al. in a recent edition of Neurogenetics [1]. The
authors have presented a study on two polymorphisms, one
of those a functional length polymorphism in the promoter
region of the monoamineoxidase A (MAOA) gene, in 20
cases of sudden infant death syndrome (SIDS) and five
cases of stillbirth compared to healthy controls. The main
conclusion from the paper seems to be that MAOA allele
4R (with increased transcriptional activity) is significantly
more common in SIDS than in controls.
There are, however, severe concerns that this conclusion
could be incorrect:
1. Themostproblematicpointofthestudyisthattheauthors
obviously were not aware that MAOA is an X-
chromosomal locus. They tested 25 cases, 13 of these
maleand12female,and–ascanbededucedfromTable2
inthispaper-areoftheopinionthatbydoingso50alleles
are included into the study. However, they tested only 37
alleles, as males have only one allele for this X-
chromosomal locus, whereas typing fewer alleles is
bound to result in weaker statistical evidence.
2. There are also other less severe but still important
problems: The case sample is extremely small and
inhomogeneous. In fact, this study seems to repeat
the results presented in a previous publication by the
same authors [2] but for five cases of stillbirth that
were added. From our point of view, it might be
worth to discuss whether stillbirth and SIDS might
have the same biological background, but it seems to
be premature to pool these entities for a disease
association study. In contrast, association studies in
SIDS are normally conducted on case groups of 100 or
more [3, 4].
Therefore, in order to check the results by Filonzi et al.
in an independent study, we typed the MAOA locus using
PCR with fluorescence-labeled primers and capillary
electrophoresis in small cohorts of 22 male and 21 female
SIDS cases and 20 male and 21 female controls.
In contrary to the findings of Filonzi et al., we found a –
however, statistically insignificant – trend towards a lower
incidence of allele 4 in male, but not in female SIDS cases
(Table 1).
We thus conclude that a potential association of SIDS
and MAOA promoter polymorphism is worth to be further
studied in a larger sample but that the conclusions drawn in
the study by Filonzi et al. might very well be misleading.
The X-chromosomal location of this polymorphism is most
intriguing, as there is a male preponderance in SIDS and
linkage to an X-chromosomal locus might be an explanation
for this phenomenon [5].
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Table 1 Alleles for the X-chromosomal MAOA promoter polymor-
phism in 22 male and 21 female SIDS victims (above) and 20 male
and 21 female controls (below)
Allele Male Female
SIDS
2 1 0.045 0 0
3 12 0.545 12 0.286
3, 5 0 0 0 0
4 8 0.364 30 0.714
5 1 0.045 0 0
Number 22 42
Controls
20 0 0 0
3 7 0.350 16 0.381
3, 5 0 0 0 0
4 13 0.650 26 0.619
50 0 0 0
Number 20 42
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